X-group (possible homology)

844 Transcriptional factor tubby, C-terminal domain

Open in classification tree →

Ligands and drugs

372

Member domains

with ligand contacts (≤ 4 Å)

2.4% of members

with DrugDomain annotations

2.7% of members

with a DrugBank compound

2.2% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

Proteins with classified ligands

Superclasses bound (of 23)

—

Superclasses per 20 proteins

fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

Superclass	Proteins	Expected	0.25×observed / expected4×	Ratio	Significance
Organic oxygen compounds	2	0.4		5.09×	not tested
Organic acids and derivatives	1	0.3		3.28×	not tested

enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBank	PDB ligand	Name	Domains
DB02028	IBS	(1R,2R,3S,4R,6S)-3,4,6-Trihydroxy-5-{[(S)-hydroxy(3-hydroxy-2-oxopropoxy)phosphoryl]oxy}-1,2-cyclohexanediyl bis[dihydrogen (phosphate)]	2
DB03401	I3P	1D-myo-inositol 1,4,5-trisphosphate	2

Most frequently bound compounds

PDB ligand	Name	Domains in contact
3DP	3-(N,N-DIMETHYLOCTYLAMMONIO)PROPANESULFONATE	2
I3P	D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE	2
IBS	L-ALPHA-GLYCEROPHOSPHO-D-MYO-INOSITOL-4,5-BIS-PHOSPHATE	1